Structured Ribosome CFPS for Portable High-Yield Protein Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current protein synthesis methods, including cell-based and cell-free systems, are inadequate for rapid, portable, and scalable production of therapeutic proteins, especially for point-of-care therapeutics and biopharmaceutical applications, due to low yields, genetic instability, and impractical production scales.
Innovation Solution
A cell-free protein synthesis (CFPS) system with localized ribosomes on structures, such as beads, nanotubes, or lattices, allowing for high surface-to-volume ratios and continuous reaction cycles with product collection and ribosome reuse, enhancing protein synthesis rates and scalability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If cell-based protein production systems are used, then proteins can be produced through genetic modification and cell culturing, but the process is labor-intensive, slow (months to produce a new drug lot), and cannot be scaled down into practical reactors for point-of-care therapeutics
Solution Approach 1:
The patent extracts the essential protein synthesis machinery (ribosomes, tRNAs, enzymes, cofactors) from living cells to create a cell-free system. This extraction eliminates the need for cell culturing while retaining the core translation function, enabling rapid protein production without the time-consuming steps of cell growth and genetic modification validation.
Solution Approach 2:
The patent segments the protein production process into discrete, controllable components: ribosomes attached to structured supports, purified translation mixtures, and modular reaction chambers. This segmentation allows each component to be optimized independently and assembled into scalable reactors that can produce proteins rapidly without the constraints of whole-cell systems.
2Productivity
If cell-based systems are used for protein production, then genetically-modified cells can create desired proteins, but unwanted genetic mutations occur during culturing and some proteins are unstable and/or toxic to the creating cells
Solution Approach 1:
By extracting ribosomes and translation components from living cells, the system eliminates the genomic DNA that is susceptible to mutations during culturing. The ribosomes are purified and attached to structured supports, creating a stable, non-replicating system that maintains genetic fidelity without the risks of cellular replication errors.
Solution Approach 2:
The patent employs disposable, non-living translation components that do not require long-term maintenance or culturing. The cell-free system uses purified, stable components that can be stored and deployed as needed, eliminating the reliability issues associated with maintaining genetically-modified cell lines over multiple passages.
3Ease of operation
If miniaturized CFPS technology is used, then portability is improved, but protein production is limited to single doses of up to 2 mg in 8 hours which is impractical for point-of-care therapeutic systems needing grams per day
Solution Approach 1:
The patent divides the protein production system into multiple parallel reaction chambers, each containing ribosome-attached structured supports. This modular segmentation allows the system to be scaled from small portable units to larger production reactors by simply adding more chambers in parallel, maintaining portability while increasing total output to gram-per-day levels.
Solution Approach 2:
The patent attaches ribosomes to three-dimensional structured supports (such as beads, scaffolds, or surface structures) rather than using free-floating ribosomes. This dimensional change dramatically increases the surface area available for translation reactions, enabling much higher protein production rates in the same volume, thus achieving both portability and high productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The CFPS system achieves protein synthesis rates several orders of magnitude higher than existing methods, enabling practical production of grams of proteins per day and supporting continuous, efficient protein production for therapeutic applications.
Implementation Method 1
ribosomes attached to or encapsulated within a structure... translate proteins from messenger RNA (mRNA)... in vitro translation (IVT) reactions
Data Source
AI summary
Provided herein are cell free protein synthesis (CFPS) systems comprising a plurality of ribosomes attached to or encapsulated within a structure, or a plurality of structures, and, optionally, a solid support. Also provided are related kits and uses of the CFPS systems. Methods of producing a protein and methods of treating a disease are provided herein.